Agreed. The biggest benefit is in doing this better NIT in trials to make recruitment easier and assessment better going forward. This does limit sites that could recruit though.
Maybe there would have been so many late stage failures in NASH had earlier stages used MRE in combination with biomarkers.
"People are best convinced by reasons they discover themselves"
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.